Alexander S. Krupnick

Innate immunity in lung transplantation.

Adenosine A2A receptor agonist (regadenoson) in human lung transplantation.

Bacterial products in donor airways prevent the induction of lung transplant tolerance.

Influence of broader geographic allograft sharing on outcomes and cost in smaller lung transplant centers.

Ex Vivo Lung Perfusion: Current Achievements and Future Directions.

Lymphatic drainage from bronchus-associated lymphoid tissue in tolerant lung allografts promotes peripheral tolerance.

Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy.

The impact of the American Association for Thoracic Surgery on National Institutes of Health grant funding for cardiothoracic surgeons.

Neoadjuvant Multimodality Induction Therapy for Locally Advanced Initially Unresectable Lung Cancer: A New Hope.

Solving the Conundrum of Eosinophils in Alloimmunity.

Necroptosis triggers spatially restricted neutrophil-mediated vascular damage during lung ischemia reperfusion injury.

The Ferret Era of Experimental Lung Transplantation Is Upon Us.

Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells.

A reengineered common chain cytokine augments CD8+ T cell-dependent immunotherapy.

Role of tertiary lymphoid organs in the regulation of immune responses in the periphery.

Loss of stromal cell Thy-1 plays a critical role in lipopolysaccharide induced chronic lung allograft dysfunction.

Updated Views on Neutrophil Responses in Ischemia-Reperfusion Injury.

The role of neutrophil extracellular traps in acute lung injury.

Reprogramming alveolar macrophage responses to TGF-β reveals CCR2+ monocyte activity that promotes bronchiolitis obliterans syndrome.

Full-length IL-33 augments pulmonary fibrosis in an ST2- and Th2-independent, non-transcriptomic fashion.

Successful lung transplantation using an allograft from a COVID-19-recovered donor: a potential role for subgenomic RNA to guide organ utilization.

Regadenoson Reduces Soluble Receptor for Advanced Glycation End-Products in Lung Recipients.

Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice.

Commentary on: Risk of prolonged ischaemic time linked to use of cardio-pulmonary bypass during implantation for lung transplantation in the United Kingdom.

Smoking exposure-induced bronchus-associated lymphoid tissue in donor lungs does not prevent tolerance induction after transplantation.

Pulmonary transplantation-is it a long-term solution?

Monitoring regulatory T cells as a prognostic marker in lung transplantation.

Eosinophils restrain humoral alloimmunity after lung transplantation.

Nanoparticle targeting of neutrophil glycolysis prevents lung ischemia-reperfusion injury.